Clinical Trials Directory

Trials / Completed

CompletedNCT01949428

House Dust Mite Observational Study

A Field Study to Observe Symptom Scores and Allergy Medication Usage in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
Circassia Limited · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

A Field Study to Observe Symptom Scores and Allergy Medication Usage in Subjects with a History of House Dust Mite-Induced Rhinoconjunctivitis

Detailed description

House Dust Mites (HDM) are arachnids that infest bedding, carpet, upholstered furniture and fabric. Like many other allergens, exposure to HDMA in sensitised patients is associated with poorer lung function, greater medication requirements and more asthma symptoms as well as chronic rhinosinusitis symptoms. In contrast to other allergens, there is evidence that HDMA leads to the development of asthma, in addition to exacerbating pre-existing asthma in HDM-sensitised patients. The proposed observational study is designed to gather information on subjects with HDM-related rhinoconjunctivitis.

Conditions

Timeline

Start date
2013-09-01
Primary completion
2014-03-01
Completion
2014-03-01
First posted
2013-09-24
Last updated
2014-05-15

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01949428. Inclusion in this directory is not an endorsement.